OptiBiotix shares surge 13.5% as company plans SweetBiotix showcase for investors

OptiBiotix Health PLC (AIM:OPTI, OTCQB:OPTBF), the AIM-listed life sciences company developing gut microbiome products and healthy sugar substitutes, saw its shares jump 13.5% to 5.68p after announcing plans to demonstrate its SweetBiotix products to shareholders at a London event in June. The company reported a breakthrough in the manufacture of SweetBiotix in November 2025, achieving higher yields of a purer, more concentrated and better-tasting product with lower ingredient and production costs.